Home Healthcare IT Benign Prostatic Hyperplasia Treatment Market Size, Key Drivers, Trends And Opportunities

Benign Prostatic Hyperplasia Treatment Market Size & Outlook, 2025-2033

Benign Prostatic Hyperplasia Treatment Market Size, Share & Trends Analysis Report By Treatment Type (Pharmacological Treatment (Alpha-blockers, 5-Alpha Reductase Inhibitors, Phosphodiesterase-5 Inhibitors, Others), Minimally Invasive Procedures (Transurethral Resection of the Prostate, Laser Therapy, Prostatic Urethral Lift, Prostatic Artery Embolisation, Others), Surgical Procedures (Open Prostatectomy, Robotic-Assisted Surgery, Others)), By End-User (Hospitals, Ambulatory Surgical Centers (ASCs), Clinics, Home Care Settings), By Distribution Channel: (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2025-2033

Report Code: SRHI57351DR
Last Updated : Jun, 2025
Pages : 110
Author : Debashree Bora
Format : PDF, Excel

Market Segmentation

  1. Benign Prostatic Hyperplasia Treatment Market, By Treatment Type (2021–2033)
    1. Pharmacological Treatment (Alpha-blockers, 5-Alpha Reductase Inhibitors, Phosphodiesterase-5 Inhibitors, Others)
    2. Minimally Invasive Procedures (Transurethral Resection of the Prostate [TURP], Laser Therapy, Prostatic Urethral Lift [UroLift], Prostatic Artery Embolisation [PAE], Others)
    3. Surgical Procedures (Open Prostatectomy, Robotic-Assisted Surgery, Others)
  2. Benign Prostatic Hyperplasia Treatment Market, By End-User (2021–2033)
    1. Hospitals
    2. Ambulatory Surgical Centers (ASCs)
    3. Clinics
    4. Home Care Settings
  3. Benign Prostatic Hyperplasia Treatment Market, By Distribution Channel: (2021–2033)
    1. Hospital Pharmacies
    2. Retail Pharmacies
    3. Online Pharmacies
    1. North America
      1. North America Benign Prostatic Hyperplasia Treatment Market, By Treatment Type
        1. Pharmacological Treatment (Alpha-blockers, 5-Alpha Reductase Inhibitors, Phosphodiesterase-5 Inhibitors, Others)
          1. Minimally Invasive Procedures (Transurethral Resection of the Prostate [TURP], Laser Therapy, Prostatic Urethral Lift [UroLift], Prostatic Artery Embolisation [PAE], Others)
            1. Surgical Procedures (Open Prostatectomy, Robotic-Assisted Surgery, Others)
            2. North America Benign Prostatic Hyperplasia Treatment Market, By End-User
              1. Hospitals
                1. Ambulatory Surgical Centers (ASCs)
                  1. Clinics
                    1. Home Care Settings
                    2. North America Benign Prostatic Hyperplasia Treatment Market, By Distribution Channel:
                      1. Hospital Pharmacies
                        1. Retail Pharmacies
                          1. Online Pharmacies
                          2. U.S.
                            1. U.S. Benign Prostatic Hyperplasia Treatment Market, By Treatment Type
                              1. Pharmacological Treatment (Alpha-blockers, 5-Alpha Reductase Inhibitors, Phosphodiesterase-5 Inhibitors, Others)
                                1. Minimally Invasive Procedures (Transurethral Resection of the Prostate [TURP], Laser Therapy, Prostatic Urethral Lift [UroLift], Prostatic Artery Embolisation [PAE], Others)
                                  1. Surgical Procedures (Open Prostatectomy, Robotic-Assisted Surgery, Others)
                                  2. U.S. Benign Prostatic Hyperplasia Treatment Market, By End-User
                                    1. Hospitals
                                      1. Ambulatory Surgical Centers (ASCs)
                                        1. Clinics
                                          1. Home Care Settings
                                          2. U.S. Benign Prostatic Hyperplasia Treatment Market, By Distribution Channel:
                                            1. Hospital Pharmacies
                                              1. Retail Pharmacies
                                                1. Online Pharmacies
                                              2. Canada
                                            2. Europe
                                              1. Europe Benign Prostatic Hyperplasia Treatment Market, By Treatment Type
                                                1. Pharmacological Treatment (Alpha-blockers, 5-Alpha Reductase Inhibitors, Phosphodiesterase-5 Inhibitors, Others)
                                                  1. Minimally Invasive Procedures (Transurethral Resection of the Prostate [TURP], Laser Therapy, Prostatic Urethral Lift [UroLift], Prostatic Artery Embolisation [PAE], Others)
                                                    1. Surgical Procedures (Open Prostatectomy, Robotic-Assisted Surgery, Others)
                                                    2. Europe Benign Prostatic Hyperplasia Treatment Market, By End-User
                                                      1. Hospitals
                                                        1. Ambulatory Surgical Centers (ASCs)
                                                          1. Clinics
                                                            1. Home Care Settings
                                                            2. Europe Benign Prostatic Hyperplasia Treatment Market, By Distribution Channel:
                                                              1. Hospital Pharmacies
                                                                1. Retail Pharmacies
                                                                  1. Online Pharmacies
                                                                  2. U.K.
                                                                    1. U.K. Benign Prostatic Hyperplasia Treatment Market, By Treatment Type
                                                                      1. Pharmacological Treatment (Alpha-blockers, 5-Alpha Reductase Inhibitors, Phosphodiesterase-5 Inhibitors, Others)
                                                                        1. Minimally Invasive Procedures (Transurethral Resection of the Prostate [TURP], Laser Therapy, Prostatic Urethral Lift [UroLift], Prostatic Artery Embolisation [PAE], Others)
                                                                          1. Surgical Procedures (Open Prostatectomy, Robotic-Assisted Surgery, Others)
                                                                          2. U.K. Benign Prostatic Hyperplasia Treatment Market, By End-User
                                                                            1. Hospitals
                                                                              1. Ambulatory Surgical Centers (ASCs)
                                                                                1. Clinics
                                                                                  1. Home Care Settings
                                                                                  2. U.K. Benign Prostatic Hyperplasia Treatment Market, By Distribution Channel:
                                                                                    1. Hospital Pharmacies
                                                                                      1. Retail Pharmacies
                                                                                        1. Online Pharmacies
                                                                                      2. Germany
                                                                                      3. France
                                                                                      4. Spain
                                                                                      5. Italy
                                                                                      6. Russia
                                                                                      7. Nordic
                                                                                      8. Benelux
                                                                                      9. Rest of Europe
                                                                                    2. APAC
                                                                                      1. APAC Benign Prostatic Hyperplasia Treatment Market, By Treatment Type
                                                                                        1. Pharmacological Treatment (Alpha-blockers, 5-Alpha Reductase Inhibitors, Phosphodiesterase-5 Inhibitors, Others)
                                                                                          1. Minimally Invasive Procedures (Transurethral Resection of the Prostate [TURP], Laser Therapy, Prostatic Urethral Lift [UroLift], Prostatic Artery Embolisation [PAE], Others)
                                                                                            1. Surgical Procedures (Open Prostatectomy, Robotic-Assisted Surgery, Others)
                                                                                            2. APAC Benign Prostatic Hyperplasia Treatment Market, By End-User
                                                                                              1. Hospitals
                                                                                                1. Ambulatory Surgical Centers (ASCs)
                                                                                                  1. Clinics
                                                                                                    1. Home Care Settings
                                                                                                    2. APAC Benign Prostatic Hyperplasia Treatment Market, By Distribution Channel:
                                                                                                      1. Hospital Pharmacies
                                                                                                        1. Retail Pharmacies
                                                                                                          1. Online Pharmacies
                                                                                                          2. China
                                                                                                            1. China Benign Prostatic Hyperplasia Treatment Market, By Treatment Type
                                                                                                              1. Pharmacological Treatment (Alpha-blockers, 5-Alpha Reductase Inhibitors, Phosphodiesterase-5 Inhibitors, Others)
                                                                                                                1. Minimally Invasive Procedures (Transurethral Resection of the Prostate [TURP], Laser Therapy, Prostatic Urethral Lift [UroLift], Prostatic Artery Embolisation [PAE], Others)
                                                                                                                  1. Surgical Procedures (Open Prostatectomy, Robotic-Assisted Surgery, Others)
                                                                                                                  2. China Benign Prostatic Hyperplasia Treatment Market, By End-User
                                                                                                                    1. Hospitals
                                                                                                                      1. Ambulatory Surgical Centers (ASCs)
                                                                                                                        1. Clinics
                                                                                                                          1. Home Care Settings
                                                                                                                          2. China Benign Prostatic Hyperplasia Treatment Market, By Distribution Channel:
                                                                                                                            1. Hospital Pharmacies
                                                                                                                              1. Retail Pharmacies
                                                                                                                                1. Online Pharmacies
                                                                                                                              2. Korea
                                                                                                                              3. Japan
                                                                                                                              4. India
                                                                                                                              5. Australia
                                                                                                                              6. Taiwan
                                                                                                                              7. South East Asia
                                                                                                                              8. Rest of Asia-Pacific
                                                                                                                            2. Middle East and Africa
                                                                                                                              1. Middle East and Africa Benign Prostatic Hyperplasia Treatment Market, By Treatment Type
                                                                                                                                1. Pharmacological Treatment (Alpha-blockers, 5-Alpha Reductase Inhibitors, Phosphodiesterase-5 Inhibitors, Others)
                                                                                                                                  1. Minimally Invasive Procedures (Transurethral Resection of the Prostate [TURP], Laser Therapy, Prostatic Urethral Lift [UroLift], Prostatic Artery Embolisation [PAE], Others)
                                                                                                                                    1. Surgical Procedures (Open Prostatectomy, Robotic-Assisted Surgery, Others)
                                                                                                                                    2. Middle East and Africa Benign Prostatic Hyperplasia Treatment Market, By End-User
                                                                                                                                      1. Hospitals
                                                                                                                                        1. Ambulatory Surgical Centers (ASCs)
                                                                                                                                          1. Clinics
                                                                                                                                            1. Home Care Settings
                                                                                                                                            2. Middle East and Africa Benign Prostatic Hyperplasia Treatment Market, By Distribution Channel:
                                                                                                                                              1. Hospital Pharmacies
                                                                                                                                                1. Retail Pharmacies
                                                                                                                                                  1. Online Pharmacies
                                                                                                                                                  2. UAE
                                                                                                                                                    1. UAE Benign Prostatic Hyperplasia Treatment Market, By Treatment Type
                                                                                                                                                      1. Pharmacological Treatment (Alpha-blockers, 5-Alpha Reductase Inhibitors, Phosphodiesterase-5 Inhibitors, Others)
                                                                                                                                                        1. Minimally Invasive Procedures (Transurethral Resection of the Prostate [TURP], Laser Therapy, Prostatic Urethral Lift [UroLift], Prostatic Artery Embolisation [PAE], Others)
                                                                                                                                                          1. Surgical Procedures (Open Prostatectomy, Robotic-Assisted Surgery, Others)
                                                                                                                                                          2. UAE Benign Prostatic Hyperplasia Treatment Market, By End-User
                                                                                                                                                            1. Hospitals
                                                                                                                                                              1. Ambulatory Surgical Centers (ASCs)
                                                                                                                                                                1. Clinics
                                                                                                                                                                  1. Home Care Settings
                                                                                                                                                                  2. UAE Benign Prostatic Hyperplasia Treatment Market, By Distribution Channel:
                                                                                                                                                                    1. Hospital Pharmacies
                                                                                                                                                                      1. Retail Pharmacies
                                                                                                                                                                        1. Online Pharmacies
                                                                                                                                                                      2. Turkey
                                                                                                                                                                      3. Saudi Arabia
                                                                                                                                                                      4. South Africa
                                                                                                                                                                      5. Egypt
                                                                                                                                                                      6. Nigeria
                                                                                                                                                                      7. Rest of MEA
                                                                                                                                                                    2. LATAM
                                                                                                                                                                      1. LATAM Benign Prostatic Hyperplasia Treatment Market, By Treatment Type
                                                                                                                                                                        1. Pharmacological Treatment (Alpha-blockers, 5-Alpha Reductase Inhibitors, Phosphodiesterase-5 Inhibitors, Others)
                                                                                                                                                                          1. Minimally Invasive Procedures (Transurethral Resection of the Prostate [TURP], Laser Therapy, Prostatic Urethral Lift [UroLift], Prostatic Artery Embolisation [PAE], Others)
                                                                                                                                                                            1. Surgical Procedures (Open Prostatectomy, Robotic-Assisted Surgery, Others)
                                                                                                                                                                            2. LATAM Benign Prostatic Hyperplasia Treatment Market, By End-User
                                                                                                                                                                              1. Hospitals
                                                                                                                                                                                1. Ambulatory Surgical Centers (ASCs)
                                                                                                                                                                                  1. Clinics
                                                                                                                                                                                    1. Home Care Settings
                                                                                                                                                                                    2. LATAM Benign Prostatic Hyperplasia Treatment Market, By Distribution Channel:
                                                                                                                                                                                      1. Hospital Pharmacies
                                                                                                                                                                                        1. Retail Pharmacies
                                                                                                                                                                                          1. Online Pharmacies
                                                                                                                                                                                          2. Brazil
                                                                                                                                                                                            1. Brazil Benign Prostatic Hyperplasia Treatment Market, By Treatment Type
                                                                                                                                                                                              1. Pharmacological Treatment (Alpha-blockers, 5-Alpha Reductase Inhibitors, Phosphodiesterase-5 Inhibitors, Others)
                                                                                                                                                                                                1. Minimally Invasive Procedures (Transurethral Resection of the Prostate [TURP], Laser Therapy, Prostatic Urethral Lift [UroLift], Prostatic Artery Embolisation [PAE], Others)
                                                                                                                                                                                                  1. Surgical Procedures (Open Prostatectomy, Robotic-Assisted Surgery, Others)
                                                                                                                                                                                                  2. Brazil Benign Prostatic Hyperplasia Treatment Market, By End-User
                                                                                                                                                                                                    1. Hospitals
                                                                                                                                                                                                      1. Ambulatory Surgical Centers (ASCs)
                                                                                                                                                                                                        1. Clinics
                                                                                                                                                                                                          1. Home Care Settings
                                                                                                                                                                                                          2. Brazil Benign Prostatic Hyperplasia Treatment Market, By Distribution Channel:
                                                                                                                                                                                                            1. Hospital Pharmacies
                                                                                                                                                                                                              1. Retail Pharmacies
                                                                                                                                                                                                                1. Online Pharmacies
                                                                                                                                                                                                              2. Mexico
                                                                                                                                                                                                              3. Argentina
                                                                                                                                                                                                              4. Chile
                                                                                                                                                                                                              5. Colombia
                                                                                                                                                                                                              6. Rest of LATAM

                                                                                                                                                                                                          Available for purchase with detailed segment data, forecasts, and regional insights.

                                                                                                                                                                                                          Get This Report

                                                                                                                                                                                                          Download Free Sample

                                                                                                                                                                                                          Note: Please ensure you provide an active email address as we will be sending sample details via email.
                                                                                                                                                                                                          The button will be active once the above form is filled

                                                                                                                                                                                                          Our Clients:

                                                                                                                                                                                                          LG Electronics
                                                                                                                                                                                                          AMCAD Engineering
                                                                                                                                                                                                          KOBE STEEL LTD.
                                                                                                                                                                                                          Hindustan National Glass & Industries Limited
                                                                                                                                                                                                          Voith Group
                                                                                                                                                                                                          International Paper
                                                                                                                                                                                                          Hansol Paper
                                                                                                                                                                                                          Whirlpool Corporation
                                                                                                                                                                                                          Sony
                                                                                                                                                                                                          Samsung Electronics
                                                                                                                                                                                                          Qualcomm
                                                                                                                                                                                                          Google
                                                                                                                                                                                                          Fiserv
                                                                                                                                                                                                          Veto-Pharma
                                                                                                                                                                                                          Nippon Becton Dickinson
                                                                                                                                                                                                          Merck
                                                                                                                                                                                                          Argon Medical Devices
                                                                                                                                                                                                          Abbott
                                                                                                                                                                                                          Ajinomoto
                                                                                                                                                                                                          Denon
                                                                                                                                                                                                          Doosan
                                                                                                                                                                                                          Meiji Seika Kaisha Ltd
                                                                                                                                                                                                          LG Chemicals
                                                                                                                                                                                                          LCY chemical group
                                                                                                                                                                                                          Bayer
                                                                                                                                                                                                          Airrane
                                                                                                                                                                                                          BASF
                                                                                                                                                                                                          Toyota Industries
                                                                                                                                                                                                          Nissan Motors
                                                                                                                                                                                                          Neenah
                                                                                                                                                                                                          Mitsubishi
                                                                                                                                                                                                          Hyundai Motor Company

                                                                                                                                                                                                          We are featured on :

                                                                                                                                                                                                          Address:
                                                                                                                                                                                                          Office 515 A, Amanora Chambers,
                                                                                                                                                                                                          Amanora Park Town, Hadapsar,
                                                                                                                                                                                                          Pune 411028, Maharashtra, India.
                                                                                                                                                                                                          Contact Us:
                                                                                                                                                                                                          +1 646 905 0080 (U.S.)
                                                                                                                                                                                                          +91 8087085354 (India)
                                                                                                                                                                                                          +44 203 695 0070 (U.K.)

                                                                                                                                                                                                          sales@straitsresearch.com

                                                                                                                                                                                                          Quick Links
                                                                                                                                                                                                          Help
                                                                                                                                                                                                          Verified. Protected. Secure.
                                                                                                                                                                                                          DMCA.com Protection Status
                                                                                                                                                                                                          Secure Payments:
                                                                                                                                                                                                          Follow Us:
                                                                                                                                                                                                          www.straitsresearch.com © Copyright . All rights Reserved.